Articles with "weeks versus" as a keyword



Photo from wikipedia

Pregnancy outcome after multifetal pregnancy reduction of triplets to twins versus reduction to singletons.

Sign Up to like & get
recommendations!
Published in 2019 at "Reproductive biomedicine online"

DOI: 10.1016/j.rbmo.2019.12.014

Abstract: RESEARCH QUESTION Does fetal reduction of triplet pregnancies to singleton result in superior obstetric and neonatal outcomes compared with triplets reduced to twins? DESIGN A historical cohort study including 285 trichorionic and dichorionic triplet pregnancies… read more here.

Keywords: reduction; reduction singletons; pregnancy; reduction triplets ... See more keywords
Photo by kattrinnaaaaa from unsplash

A comparison of urethral catheterization duration - three weeks versus two weeks after bulbar urethroplasty

Sign Up to like & get
recommendations!
Published in 2021 at "Scandinavian Journal of Urology"

DOI: 10.1080/21681805.2021.1945141

Abstract: Abstract Objective To determine the incidence of bacteriuria, urinary tract infections (UTI), and significant extravasation of contrast on initial postoperative pericatheter retrograde urethrogram (pcRUG) after bulbar urethroplasty in relation to duration of urethral catheterization (DUC)… read more here.

Keywords: urethral catheterization; two weeks; bulbar urethroplasty; three weeks ... See more keywords
Photo from wikipedia

Routine Ultrasound at 30th–33rd weeks versus 30th–33rd and 35th–37th weeks in Low-Risk Pregnancies: A Randomized Trial

Sign Up to like & get
recommendations!
Published in 2022 at "Fetal Diagnosis and Therapy"

DOI: 10.1159/000527112

Abstract: Introduction: The aim of this study was to evaluate the accuracy of 35–37 weeks’ ultrasound for fetal growth restriction (FGR) detection and the impact of 30th–33rd weeks versus 30th–33rd and 35th–37th weeks’ ultrasound on perinatal… read more here.

Keywords: 33rd weeks; 35th 37th; 30th 33rd; 37th weeks ... See more keywords
Photo by nci from unsplash

Any regression of tumor (ART) within 12 weeks versus RECIST 1.1 response category as an intermediate endpoint to assess the activity of immune checkpoint inhibitors (ICIs) for metastatic urothelial carcinoma (mUC).

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2020.38.6_suppl.473

Abstract: 473Background: Many ICIs are approved to treat mUC following platinum-based chemo and as 1st-line therapy for selected patients (pts). While RECIST 1.1 responses are generally durable and associate... read more here.

Keywords: muc; art within; regression tumor; within weeks ... See more keywords